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Abstract
 .Induction of the expression of the thioredoxin TRX gene, producing a key protein in regulating cellular functions
through redox reaction as well as being a radioprotector, was followed after ionizing irradiation of lymphocytes from human
donors. The TRX mRNA level increased to a peak, 5.7-fold higher than the control at maximum, 6 h after irradiation, and
then decreased. The optimum radiation dose for enhancement of induction of the TRX mRNA was 0.25 Gy. The TRX
protein also increased to a peak, a 3-fold increase at maximum, with the same timing as that for TRX mRNA. q 1997
Elsevier Science B.V.
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1. Introduction
Biological effects of low-level ionizing radiation
are now becoming increasingly important from the
w xviewpoint of human health in the environment 1 .
At the molecular level, ionizing radiation modu-
lates expression of a number of mammalian genes.
w xThese include plasminogen activator gene 2 , proto-
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w xoncogenes 3–5 , and genes controlling cell growth
w x w x w xsuch as cyclin B 6 and p53 7 , and apoptosis 8 .
Involvement of a more numerous variety of
radiation-inducible genes controlling cellular func-
tions was shown from analysis of radiation-inducible
w xtranscripts 9 . The presence of the responsive ele-
w xment to ionizing radiation 10 and the alteration of
w xtranscription factor binding after radiation 11 indi-
cate that ionizing radiation modulates gene expres-
sion at the transcription level.
The molecular mechanism of these ionizing radia-
tion-inducible events is thought to be related to such
radiation-inducible biological phenomena as adaptive
w x w xresponse 12 and induced radioresistance 13 , al-
though the molecular data have been obtained with a
relatively high radiation dose.
On the other hand, the redox status of a number of
gene products also regulates various cellular func-
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tions, such as the DNA binding activity of Jun and
Fos and the HAP-1rRef-1 apurinic endonuclease-
w xDNA repair activity 14,15 and the p53 function
w x16 . Recently, the redoxrDNA repair protein, Ref-1,
was shown to be essential for early embryonic devel-
w xopment in mice 17 .
 .Thioredoxin TRX is a key protein which controls
cellular redox status. TRX was originally purified
w xfrom Escherichia coli 18 and shown to be an
oxidoreductase enzyme consisting of 104 amino acids
w x19,20 . The nucleotide sequence of the human TRX
w xgene has been determined 21 and was shown to be
identical to that of adult T cell leukemia-derived
w x w xfactor 22,23 , having cytokine activity 24 . Interest-
ingly, TRX is a surface-associated sulfhydryl protein
w x w x25 and a radio-protector 26 . TRX reduces hydro-
w xgen peroxide and scavenges free radicals 27,28 .
Therefore, TRX gene expression potentially can play
an important role in cellular functions responding to
radiation.
It would be interesting to test whether ionizing
radiation can induce TRX. In this study, we observed
the cellular TRX mRNA and protein levels after
ionizing irradiation of human lymphocytes and found
that TRX mRNA as well as TRX protein is indeed
induced.
2. Materials and methods
2.1. Cells
Fresh human venous blood was obtained from one
 .of the authors, HT donor A , and was used immedi-
ately for experiments after sampling. Other blood
samples were obtained from healthy male donors
 .B–E supplied by the Japan Red Cross Blood Cen-
ter, Tokyo, and were kept at 48C overnight after
separation of serum. Lymphocytes were isolated by
centrifugation at 1000 rpm for 30 min in a layer of
 .LYMPHOSEPAL Nippon Gene, Toyama, Japan .
Cells were washed once in phosphate-buffered saline
and hemolyzed with hypotonic solution. They were
then washed with the cell culture medium, RPMI
 .1640 Nissui, Tokyo, Japan supplemented with 10%
heat-treated fetal calf serum GIBCO BRL; Gaithers-
.burg, MD, USA , 2 mmol of L-glutamine, 0.2 mmol
of sodium pyruvate and 100 units of penicillinrml.
Lymphocytes were suspended at 106 cellsrml in the
medium and kept at 378C for 1 h prior to irradiation.
w xThe human B-lymphoblastoid cell line 1G8 29 ,
which was immortalized after infection with
 .Epstein-Barr virus EBV , the Jurkat cell line, and
lymphocytes from a human donor stimulated for
 .growth of T-cells by interleukin 2 IL-2 and CD3,
provided by Dr. Sekine, National Cancer Center,
were also used as TRX expression controls. They
were incubated in the same medium as described.
2.2. Radiation and chemical treatment
Lymphocytes suspended in the culture medium at
106 cellsrml were exposed at room temperature to
various single doses of g rays generated by a 60Co
 .source Toshiba, Tokyo, Japan at a dose-rate of 0.72
Gyrmin, as calibrated by a dosimeter Farmer
.2570r1B, NE Technology, Reading, UK , or to X-
rays generated by a 150 Kvp generator Model MBR-
.1505R2, Hitachi, Tokyo, Japan with filters of 0.2
mm Cu and 1.0 mm Al at a dose rate of 0.25
Gyrmin. Irradiated cells were incubated at 378C in
humidified 5% CO r95% air for various periods of2
time. Aliquots, containing 107 cells each, were used
for extraction of RNA and protein. As a positive
control, cells suspended at 106 cellsrml in the cul-
ture medium were treated with 1 ng of 12-O-tetrade-
 .canoilphorbol-13-acetate TPA per ml for various
periods of time under the culture conditions.
2.3. Measurements of TRX mRNA and TRX protein
Total cellular RNA was extracted according to
protocols of the manufacturer of the ISOGEN kit
 .Nippon Gene, Toyama, Japan , and analyzed accord-
w xing to the method described by Sambrook et al. 30 .
Briefly, 107 cells for each aliquot were collected by
 .centrifugation 1500 rpm, 10 min , suspended in
ISOGEN, containing 10 mM Tris-HCl, pH 7.6, 250
mM NaCl, 0.5% NP-40, and 1 mM phenylmethyl-
sulfonyl fluoride, and then sonicated. RNA was iso-
lated after precipitation with isopropanol. RNA 5
.mg was denatured with formaldehyde for 15 min at
 .658C, and subjected to electrophoresis 5 Vrcm in
1% agarose gel containing 6.6% of formaldehyde.
RNA was then transferred to a nitrocellulose mem-
brane NITROPLUS; Micron Separations, Westboro,
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.MA, USA , which was then prehybridized with
salmon sperm DNA for 4 h, followed by hybridiza-
tion for 18–20 h at 458C with a 32P-labeled probe of
 .the TRX cDNA 600 bp in the hybridization solu-
tion. The Northern blots were taken by autoradiog-
raphy on an X-ray film Type AR, KODAK;
.Rochester, NY, USA . To quantify TRX mRNA
amounts, the blots were taken on an imaging plate
and the density was measured by an analyzer Model
BAS2000, FUJIX PICTOGRAM; Fuji Film, Tokyo,
.Japan . The exposure time was usually overnight for
X-ray film and 1 h for the imaging plate. The linear
intensity response portion was used to obtain relative
TRX mRNA levels. As controls, the 18S ribosomal
 .RNA 1900 bp bands were taken by rehybridization
on the same membrane.
To extract total proteins, irradiated cells were
washed with phosphate-buffered saline and sus-
pended in lysis solution containing 10 mM Tris-HCl,
pH 7.6; 250 mM NaCl; 0.5% NP-40 and 1 mM
phenylmethylsulfonyl fluoride. Proteins were ex-
tracted by freeze-thawing five times followed by
sonication. Amounts of TRX proteins in these ex-
w xtracts were measured by the ELISA method 31 ,
using anti-TRX antibody developed by the National
Cancer Center and Immuno-Biological Laboratories
 .Fujioka, Gumma-ken, Japan . Recombinant human
 .TRX IMO, Stockholm, Sweden was used to obtain
the calibration curve.
3. Results
Expression of TRX mRNA in human lymphocytes
was induced after irradiation of lymphocytes in the
culture medium with single radiation doses. Fig. 1
shows Northern blots of TRX mRNA of lymphocytes
 .separated from fresh human blood donor A follow-
ing irradiation with 0.25 Gy. The TRX mRNA level
increased with time and reached a 5.7-fold higher
level after 6 h. Fig. 1 also includes the TRX mRNA
in the immortalized human B cell line 1G8, which
showed a level 11-fold higher than untreated lympho-
cytes. As loading controls, the 18S ribosomal RNA
was detected in the same membrane filter as that used
for the TRX mRNA, which remained unchanged
 .during post-irradiation incubation Fig. 1 .
Fig. 2 shows TRX mRNA levels expressed in
 .Fig. 1. Northern blots of thioredoxin TRX mRNA of human
lymphocytes incubated in the culture medium for various times
after irradiation with 0.25 Gy. Upper lanes: TRX mRNA 600
.  .nucleotides ; lower lanes: 18S ribosomal RNA 1900 nucleotides .
 .Lane 1–4: RNA total loading: 5 mg from fresh human lympho-
cytes at 0, 2, 4 and 6 h after irradiation. Lane 5: RNA total
.loading: 10 mg from the human lymphocyte cell line, 1G8, as a
positive control. Detection of 18S ribosomal RNA was under-
taken to check for gel loading errors.
various preparations of human lymphocytes. Lym-
 .phocytes prepared from fresh venous blood donor A
and the Jurkat cells showed the lowest TRX mRNA
level. Lymphocytes stimulated for growth with IL-2
and CD3 exhibited a 3.6-fold higher TRX mRNA
level. The highest TRX mRNA expression so far
measured was exhibited in the immortalized cell line
1G8.
Fig. 3 shows quantitative data of the post-irradia-
tion time course of TRX mRNA and TRX protein
levels in lymphocytes taken from different donors.
Lymphocytes freshly prepared from venous blood
 .showed the highest response Fig. 3A . The peak of
the TRX mRNA expression appeared 6 h after irradi-
ation, with a decline afterwards. Red Cross blood
 .samples Fig. 3B–E also showed the increase of
TRX mRNA level with a peak at 6–8 h after irradia-
Fig. 2. TRX mRNA levels in human lymphocytes of various
preparations and cell lines. a, lymphocytes from fresh blood of
donor A. b, Jurkat cells. c, lymphocytes from fresh blood,
stimulated for growth with IL-2 and CD3. d. 1G8 cells. Bar:
SEM.
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 .  .Fig. 3. Time course of the induction of TRX mRNA upper column and TRX protein lower column in human lymphocytes from
 .different donors after irradiation with 0.25 Gy. Age of donors all males : A, 63; B, 43; C, 41; D, 62; E, 30. TRX mRNA levels after
 .  .treatment with TPA ’ and without radiation ‘ are shown. Bars: SEM.
tion, but the increased level was lower than that of
sample from donor A. Lymphocytes treated by a
tumor promoter TPA also showed the elevated TRX
 .mRNA level with a peak at 2 h. Fig. 3A . The TRX
mRNA level in non-irradiated lymphocytes remained
 .unchanged during incubation Fig. 3A .
The TRX protein level was also tracked after
irradiation of the lymphocytes with 0.25 Gy Fig. 3,
.lower columns . The peak expression was found 6 h
after irradiation, just as for mRNA, although its
increased level was not so high as the mRNA in-
crease. The TRX protein level in non-irradiated sam-
ple A lymphocytes was 85 pgrcell or 20.3 ngrmg of
total cellular protein.
To see the dose response of the TRX mRNA and
protein induction, lymphocytes were irradiated with
various radiation doses and incubated in the culture
 .medium for 6 h Fig. 4 . The optimum dose for the
TRX mRNA increase was found to be 0.25 Gy most
clearly for lymphocytes freshly prepared from donor
A. The optimum dose for TRX mRNA and protein
appeared to be 0.25–0.5 Gy for the other samples
also.
4. Discussion
The present study showed that the expression of
the TRX gene in human lymphocytes increased with
a low dose of ionizing radiation. This increase was
 .  .Fig. 4. Dose response of the induction of TRX mRNA upper column and TRX protein lower column in human lymphocytes 6 h after
irradiation. Donors are the same as shown in Fig. 3. Dotted line: donor E. Bars: SEM.
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most clearly observed in lymphocytes prepared from
fresh blood and immediately used. Other samples
kept overnight after separation of serum also showed
an increase of TRX mRNA and protein after ionizing
irradiation, although the expression level and timing
varied. Therefore, this increase is thought to occur
commonly in human lymphocytes.
The optimum radiation dose for TRX induction
was 0.25 Gy, which is much lower than doses used
for molecular studies reviewed in Section 1. Interest-
ingly, the elevated level of p53 protein is observed in
tissue specimens of various organs of mice, with the
same optimum dose of 0.25 Gy as that in the present
w xstudy 32 .
The biological consequence of the TRX induction
by ionizing radiation is unknown at the time of the
present study. However, TRX appears to be a ubiqui-
tous source of reducing potential in mammalian cells
and it is now becoming clear from various evidences
as stated in Section 1 that the cellular redox status
may play an important regulatory role in transcription
factor activity and cell cycle control. In this conse-
quence, the TRX induction by ionizing radiation must
have some biological effects. This problem will be
pursued in a future study.
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